NCT02575781 - A Study of SAR428926 in Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 5, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions

Neoplasm Malignant

Interventions

DRUG

SAR428926

Pharmaceutical form:concentrate for solution for infusion Route of administration: intravenous

Trial Locations (3)

Investigational Site Number 2080001, København Ø

Investigational Site Number 2500001, Villejuif

Investigational Site Number 7240001, Barcelona